Recruiting

Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work

The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation. Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients. This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.

ClinicalTrials.gov IDNCT05056350
PhaseNA
Enrollment25
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Breast Cancer

About this study

The diagnosis of breast cancer and the treatments implemented have a significant impact on the professional situation. Maintaining employment and/or reintegration into working life are therefore major issues for cancer patients. This trial proposes to study the feasibility of a support/coaching program for a return to work in patients after breast cancer.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Age ≥18 years * Patients cared at the Montpellier Cancer Institute (ICM) for non-metastatic breast cancer who have received adjuvant treatment (radiotherapy and/or chemotherapy) * Patient who has completed adjuvant treatment, except for hormonotherapy * Patient practicing a profession at the time of diagnosis, looking for a job or in professional retraining at the time of diagnosis * Patient expressing spontaneously or on request of the oncologist physical or psychological difficulties in the professional field * Patient wishing to be accompanied for an adapted return to her current job or for a return to a new more adapted job * Patient who signed the informed consent after informed information by her clinician Exclusion Criteria: * Metastatic breast cancer or any other cancer within the last 5 years * Patient who haven't completed herr adjuvant treatment (chemotherapy and/or radiotherapy) * Psychological condition requiring therapeutic support (objectified by the Mini International Neuropsychiatric Interview test (MINI) by identifying a Diagnostic and Statistical Manual (DSM)-IV Axis I psychiatric disorder (American Psychiatric Association, 1994) Sheehan et al., 1998) with the patient's refusal of adequate psychiatric treatment (medicated or not) at the time of inclusion in the study * Severely impaired global cognitive functioning (objectified by an adjusted score of less than 20 on the Montreal Cognitive Assessment (MoCA) test) * Physical inability to answer questionnaires

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.